InsiderClue
Stocks · Health care · Pharmaceutical Preparations

BeOne Medicines Ltd.

ONC Clue Score63
Fiscal year ends December CIK 0001651308
$354.47 +1.24% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $354.47 −2.49% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1.1Operating income−117.1Net income−119.2Fiscal year 2017Revenue238.4 +22,179.2%Operating income−98.5Net income−93.1Fiscal year 2018Revenue198.2 −16.8%Operating income−705.8Net income−673.8Fiscal year 2019Revenue428.2 +116.0%Operating income−959.9Net income−948.6EPS, diluted−1.22Fiscal year 2020Revenue308.9 −27.9%Operating income−1,657.7Net income−1,625.0EPS, diluted−1.50Fiscal year 2021Revenue1,176.3 +280.8%Operating income−1,438.7Net income−1,457.8EPS, diluted−1.21Fiscal year 2022Revenue1,415.9 +20.4%Operating income−1,789.7Net income−2,003.8EPS, diluted−1.49Fiscal year 2023Revenue2,458.8 +73.7%Operating income−1,207.7Net income−881.7EPS, diluted−0.65Fiscal year 2024Revenue3,810.2 +55.0%Operating income−568.2Net income−644.8EPS, diluted−0.47Fiscal year 2025Revenue5,343.0 +40.2%Operating income447.1Net income286.9EPS, diluted0.19
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.1 238.4 198.2 428.2 308.9 1,176.3 1,415.9 2,458.8 3,810.2 5,343.0
Growth +22,179.2% −16.8% +116.0% −27.9% +280.8% +20.4% +73.7% +55.0% +40.2%
Operating income −117.1 −98.5 −705.8 −959.9 −1,657.7 −1,438.7 −1,789.7 −1,207.7 −568.2 447.1
Net income −119.2 −93.1 −673.8 −948.6 −1,625.0 −1,457.8 −2,003.8 −881.7 −644.8 286.9
Growth
EPS, diluted n/a n/a n/a −1.22 −1.50 −1.21 −1.49 −0.65 −0.47 0.19
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Operating margin−10,940.2%Net margin−11,141.8%Free cash flow margin−10,562.1%Fiscal year 2017Operating margin−41.3%Net margin−39.1%Free cash flow margin−14.1%Fiscal year 2018Operating margin−356.1%Net margin−339.9%Free cash flow margin−311.8%Fiscal year 2019Operating margin−224.2%Net margin−221.5%Free cash flow margin−196.1%Fiscal year 2020Operating margin−536.7%Net margin−526.1%Free cash flow margin−453.6%Fiscal year 2021Gross margin86.0%Operating margin−122.3%Net margin−123.9%Free cash flow margin−132.8%Fiscal year 2022Gross margin79.8%Operating margin−126.4%Net margin−141.5%Free cash flow margin−128.7%Fiscal year 2023Gross margin84.5%Operating margin−49.1%Net margin−35.9%Free cash flow margin−69.9%Fiscal year 2024Gross margin84.4%Operating margin−14.9%Net margin−16.9%Free cash flow margin−16.6%Fiscal year 2025Gross margin87.5%Operating margin8.4%Net margin5.4%Free cash flow margin17.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a n/a 86.0% 79.8% 84.5% 84.4% 87.5%
Operating margin −10,940.2% −41.3% −356.1% −224.2% −536.7% −122.3% −126.4% −49.1% −14.9% 8.4%
Net margin −11,141.8% −39.1% −339.9% −221.5% −526.1% −123.9% −141.5% −35.9% −16.9% 5.4%
Free cash flow margin −10,562.1% −14.1% −311.8% −196.1% −453.6% −132.8% −128.7% −69.9% −16.6% 17.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−89.5Capital expenditure−23.5Free cash flow−113.0Fiscal year 2017Operating cash flow12.8Capital expenditure−46.4Free cash flow−33.6Fiscal year 2018Operating cash flow−547.7Capital expenditure−70.3Free cash flow−618.0Fiscal year 2019Operating cash flow−750.3Capital expenditure−89.6Free cash flow−839.9Fiscal year 2020Operating cash flow−1,283.5Capital expenditure−117.5Free cash flow−1,401.0Fiscal year 2021Operating cash flow−1,298.7Capital expenditure−262.9Free cash flow−1,561.7Fiscal year 2022Operating cash flow−1,496.6Capital expenditure−325.4Free cash flow−1,822.1Fiscal year 2023Operating cash flow−1,157.5Capital expenditure−561.9Free cash flow−1,719.3Fiscal year 2024Operating cash flow−140.6Capital expenditure−492.7Free cash flow−633.3Fiscal year 2025Operating cash flow1,127.6Capital expenditure−185.8Free cash flow941.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −89.5 12.8 −547.7 −750.3 −1,283.5 −1,298.7 −1,496.6 −1,157.5 −140.6 1,127.6
Capital expenditure −23.5 −46.4 −70.3 −89.6 −117.5 −262.9 −325.4 −561.9 −492.7 −185.8
Free cash flow −113.0 −33.6 −618.0 −839.9 −1,401.0 −1,561.7 −1,822.1 −1,719.3 −633.3 941.7
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash87.5Total debt17.3Net cash (debt)70.2Shareholders’ equity352.9Debt to equity0.05Fiscal year 2017Cash239.6Total debt18.4Net cash (debt)221.2Shareholders’ equity669.8Debt to equity0.03Fiscal year 2018Cash712.9Total debt49.5Net cash (debt)663.4Shareholders’ equity1,739.2Debt to equity0.03Fiscal year 2019Cash618.0Total debt83.3Net cash (debt)534.7Shareholders’ equity962.2Debt to equity0.09Fiscal year 2020Cash1,382.0Total debt518.7Net cash (debt)863.3Shareholders’ equity3,869.2Debt to equity0.13Fiscal year 2021Cash4,375.7Total debt629.7Net cash (debt)3,746.0Shareholders’ equity6,132.6Debt to equity0.10Fiscal year 2022Cash3,869.6Total debt538.1Net cash (debt)3,331.4Shareholders’ equity4,383.4Debt to equity0.12Fiscal year 2023Cash3,171.8Total debt886.0Net cash (debt)2,285.8Shareholders’ equity3,537.3Debt to equity0.25Fiscal year 2024Cash2,627.4Total debt1,018.0Net cash (debt)1,609.4Shareholders’ equity3,332.2Debt to equity0.31Fiscal year 2025Cash4,547.5Total debt1,019.2Net cash (debt)3,528.3Shareholders’ equity4,361.2Debt to equity0.23
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 87.5 239.6 712.9 618.0 1,382.0 4,375.7 3,869.6 3,171.8 2,627.4 4,547.5
Total debt 17.3 18.4 49.5 83.3 518.7 629.7 538.1 886.0 1,018.0 1,019.2
Net cash (debt) 70.2 221.2 663.4 534.7 863.3 3,746.0 3,331.4 2,285.8 1,609.4 3,528.3
Shareholders’ equity 352.9 669.8 1,739.2 962.2 3,869.2 6,132.6 4,383.4 3,537.3 3,332.2 4,361.2
Debt to equity 0.05 0.03 0.03 0.09 0.13 0.10 0.12 0.25 0.31 0.23

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−89.5 12.8 −547.7 −750.3 −1,283.5 −1,298.7 −1,496.6 −1,157.5 −140.6 1,127.6
Growth −4,395.1%
1.9 4.8 10.4 18.6 31.8 46.5 66.3 87.7 171.8 141.7
Investment
−23.5 −46.4 −70.3 −89.6 −117.5 −262.9 −325.4 −561.9 −492.7 −185.8
calc −113.0 −33.6 −618.0 −839.9 −1,401.0 −1,561.7 −1,822.1 −1,719.3 −633.3 941.7
Growth
calc n/a n/a n/a −1.08 −1.29 −1.29 −1.36 −1.27 −0.46 0.64
−221.8 −356.3 −637.6 554.2 −3,168.4 640.7 1,077.1 60.0 −548.4 −276.2
Financing
380.9 490.4 1,690.5 85.7 5,202.8 3,636.9 −19.0 416.5 193.4 1,059.5

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.